Becton Dickinson & Co (BDX) stock
BDXNYSESurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 13/3015% above fair value
$215.71+1.19 (+0.55%)
Close on Nov 12, 2026Market cap $58.76BP/E 65.2Yield 1.93%
Becton Dickinson ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Becton Dickinson's ebitda for the twelve months ending Jun 30, 2026 was $4.98B, up 9.9% year over year. For fiscal 2025 it was $5.04B, up 7.6% from the year before. Over ten years it grew 9.9% a year on average. The highest annual figure on record is $5.04B in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $5.04B | +7.6% |
| FY2024 | Sep 30, 2024 | $4.68B | +6.5% |
| FY2023 | Sep 30, 2023 | $4.40B | -2.5% |
| FY2022 | Sep 30, 2022 | $4.51B | +0.7% |
| FY2021 | Sep 30, 2021 | $4.48B | +48.0% |
| FY2020 | Sep 30, 2020 | $3.03B | -24.6% |
| FY2019 | Sep 30, 2019 | $4.01B | +15.1% |
| FY2018 | Sep 30, 2018 | $3.49B | +33.6% |
| FY2017 | Sep 30, 2017 | $2.61B | +2.6% |
| FY2016 | Sep 30, 2016 | $2.54B | +29.5% |
| FY2015 | Sep 30, 2015 | $1.97B | -9.4% |
| FY2014 | Sep 30, 2014 | $2.17B | +20.4% |
| FY2013 | Sep 30, 2013 | $1.80B | -13.0% |
| FY2012 | Sep 30, 2012 | $2.07B | -4.2% |
| FY2011 | Sep 30, 2011 | $2.16B | +4.2% |
| FY2010 | Sep 30, 2010 | $2.07B | +0.9% |
| FY2009 | Sep 30, 2009 | $2.05B | +4.8% |
| FY2008 | Sep 30, 2008 | $1.96B | +20.6% |
| FY2007 | Sep 30, 2007 | $1.63B | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $1.23B | -6.6% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $656.00M | -30.9% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $1.17B | +10.0% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $1.93B | +59.8% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $1.31B | +12.3% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $950.00M | -27.2% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $1.06B | +6.0% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $1.21B | +29.1% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $1.17B | +4.5% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $1.31B | +9.6% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $1.00B | -13.2% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $936.00M | -12.5% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $1.12B | +2.7% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $1.19B | +7.1% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $1.15B | -6.9% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $1.07B | +11.2% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $1.09B | +6.2% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $1.11B | +12.1% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $1.24B | -31.1% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $962.00M | +388.3% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $1.03B | +15.1% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $992.00M | +9.4% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $1.80B | +74.2% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $197.00M | -70.3% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $892.00M | -25.7% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $907.00M | +29.8% |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $1.03B | -28.9% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $664.00M | -41.9% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $1.20B | +11.1% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $699.00M | -5.4% |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $1.45B | +175.9% |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $1.14B | +47.7% |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $1.08B | +1828.6% |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $739.00M | +4.5% |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | $526.00M | -51.0% |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $773.00M | +109.5% |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $56.00M | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $707.00M | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | $1.07B | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | $369.00M | – |
See a number that looks wrong?